Introduction to Global Burden of Disease (GBD)

1. Introduction: Why Measure Disease Burden?

Understanding population health requires more than simply counting deaths. Traditional health statistics often focus on mortality alone, which fails to capture the full impact of disease, particularly non-fatal conditions such as disability, mental illness, and chronic disease.

The Global Burden of Disease (GBD) framework was developed to address this limitation by providing a comprehensive and comparable measure of health loss across populations, diseases, and time .

At its core, GBD answers a critical question:

How much healthy life is lost due to diseases, injuries, and risk factors?

This approach is essential for:

Priority setting in public health
Resource allocation
Evaluating interventions
Comparing health systems globally

2. Concept of Burden of Disease

2.1 Definition

The burden of disease refers to the total impact of disease and injury, including:

Premature death (mortality)
Disability (morbidity)

These are combined into a single metric known as:

Disability-Adjusted Life Years (DALYs)

One DALY = one lost year of healthy life
It reflects both:
- Years of Life Lost (YLL) due to premature death
- Years Lived with Disability (YLD)

2.2 Formula

[
DALY = YLL + YLD
]

This unified metric allows:

Cross-country comparisons
Comparison across diseases
Time trend analysis

The GBD project emphasizes that health loss is not just death, but also reduced quality of life.

3. Historical Development of GBD

The GBD framework originated in the early 1990s, commissioned by the World Bank and later expanded by WHO and global collaborators.

Key milestones:

1990: First comprehensive global assessment
1993: Featured in World Development Report (Investing in Health)
2010 onward: Expansion to hundreds of diseases and risk factors
2015+: Annual updates introduced
2019: Includes over 200 diseases, 990 locations, and new risk factors

The project is now coordinated globally and represents one of the largest epidemiological collaborations in history.

4. Why GBD Is Different from Traditional Health Statistics

Traditional approaches suffer from three major limitations:

4.1 Fragmentation of Data

Many countries lack reliable mortality or morbidity data.

4.2 Ignoring Non-Fatal Outcomes

Conditions like:

Depression
Dementia
Blindness

are often excluded despite large impacts on quality of life.

4.3 Lack of Comparability

Health data often cannot compare:

Different diseases
Different populations
Cost-effectiveness of interventions

The GBD addresses these by:

Including both fatal and non-fatal conditions
Using standardized methods
Enabling comparison using a single metric (DALYs)

5. Core Methodological Framework

5.1 Time as a Common Currency

GBD uses time (years) as the fundamental unit:

Years lost due to death
Years lived with disability

This allows combining mortality and morbidity into one measure.

5.2 Components of DALYs

(A) Years of Life Lost (YLL)

Calculated as:
[
YLL = Number\ of\ deaths × Standard\ life\ expectancy\ at\ age\ of\ death
]

GBD assumes a standard life expectancy:

~80 years for men
~82.5 years for women

This ensures equity across populations.

(B) Years Lived with Disability (YLD)

YLD depends on:

Duration of disease
Severity of disability

Severity is expressed as a disability weight (0–1):

0 = perfect health
1 = equivalent to death

These weights are derived using structured methods involving expert and population judgments.

6. Value Judgements in GBD

GBD is not purely technical—it includes explicit societal value choices.

Key considerations include:

6.1 Life Expectancy Standard

A universal standard ensures fairness across countries.

6.2 Age Weighting

Years of life in young adulthood are often given more weight due to:

Economic productivity
Social roles

This reflects societal preferences .

6.3 Discounting Future Health

Future health is often valued less than present health:

Standard discount rate: ~3% per year

This affects:

Preventive interventions
Long-term policy planning

6.4 Equity Principle

GBD follows an egalitarian approach:

All lives are valued equally
Socioeconomic status is not considered

This avoids bias in measurement.

7. Classification of Diseases in GBD

GBD organizes diseases into three major groups:

Group I:

Communicable diseases
Maternal conditions
Perinatal conditions
Nutritional deficiencies

Group II:

Non-communicable diseases (NCDs)

Group III:

Injuries

This structure enables systematic global comparison .

8. Epidemiological Transition

One of the most important findings of GBD is the global shift in disease patterns.

8.1 Transition Pattern

Decline in infectious diseases
Rise in non-communicable diseases

By 2020:

NCDs expected to account for ~70% of deaths in developing regions

8.2 Drivers

Aging populations
Urbanization
Lifestyle changes

This transition creates major challenges for health systems.

9. Major Causes of Death and Disability

According to GBD 2019:

Top Causes of Death

Ischaemic heart disease
Stroke
Chronic obstructive pulmonary disease
Lower respiratory infections
Neonatal conditions
Lung cancer
Alzheimer’s disease
Diarrhoeal diseases
Diabetes
Kidney disease

Top Causes of DALYs

Neonatal conditions
Ischaemic heart disease
Stroke
Lower respiratory infections
Diarrhoeal diseases
Road injuries
COPD
Diabetes
Tuberculosis
Congenital anomalies

10. Risk Factors in GBD

GBD also measures risk factors contributing to disease burden, including:

Tobacco use
Alcohol consumption
Poor diet
Unsafe water and sanitation
Environmental risks

For example:

Tobacco is projected to become the leading cause of disease burden globally

This enables prevention-focused policymaking.

11. Policy Relevance of GBD

GBD provides critical evidence for:

11.1 Health Policy

Identifying priority diseases
Allocating resources efficiently

11.2 Economic Evaluation

Cost-effectiveness analysis
Health system planning

11.3 Global Comparisons

Benchmarking countries
Tracking progress toward SDGs

12. Example: Australia Burden of Disease

National studies (e.g., Australia) use GBD methods to:

Estimate burden across diseases
Compare across years (2003–2023)
Inform national policy

This demonstrates local applicability of global frameworks.

13. Link to Palliative Care

GBD highlights end-of-life suffering and unmet needs, particularly:

Over 56 million people need palliative care annually
Only ~14% receive it globally

This underscores:

Health system gaps
Need for integrated care

GBD therefore supports:

Universal health coverage
Holistic care approaches

14. Strengths of GBD

14.1 Comprehensive

Includes mortality + morbidity

14.2 Comparable

Across countries, diseases, and time

14.3 Policy-Relevant

Supports decision-making

14.4 Transparent

Explicit assumptions and values

15. Limitations of GBD

15.1 Data Quality

Dependent on available epidemiological data

15.2 Value Judgements

Age weighting
Discounting

15.3 Complexity

Difficult for non-experts to interpret

Despite these, GBD remains the gold standard for global health measurement.

16. Key Takeaways

GBD transforms how we measure health—from death counts to health loss
DALY is the central metric combining mortality and disability
The world is undergoing a shift toward non-communicable diseases
GBD supports evidence-based public health policy
It reveals hidden burdens such as:
- Mental illness
- Chronic diseases
- Disability

17. Discussion Questions (For Students)

Why is DALY a better measure than mortality alone?
How do value judgments influence health measurement?
What are the implications of the epidemiological transition?
How can GBD data improve national health policy?

18. Suggested Further Reading (From Provided PDFs)

The Global Burden of Disease – Summary (Murray & Lopez)
Global Burden of Disease: An Introduction (2024)